Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Surface Pharmaceuticals logo — Enhancing ocular health with advanced topical solutions for...

Surface Pharmaceuticals

Enhancing ocular health with advanced topical solutions for timely and effective dry eye disease recovery.

Founded 2017 Series Unknown Total: $46.76M Biopharma, Health Care +1

General Information

Company Name Surface Pharmaceuticals
Founded Year 2017
Founders / Decision Makers
Team member
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Surface Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Surface Pharmaceuticals

Surface Pharmaceuticals is a biopharmaceutical startup founded in 2017 that is dedicated to enhancing ocular health through advanced topical solutions for timely and effective dry eye disease recovery. The company's slogan encapsulates its mission to provide innovative ophthalmology solutions through the utilization of the propriety Klarity delivery system. This unique approach aims to safeguard and restore the ocular surface, catering to the needs of patients suffering from dry eye disease. Having recently secured a significant $5.76M Venture Round investment on 10 June 2021, Surface Pharmaceuticals demonstrates promising potential within the biopharma, health care, and pharmaceutical industries. Despite the lack of specific headquarters information, the startup's focus on leveraging advanced topical formulations signifies a commitment to driving advancements in ocular health. The recent investment signifies confidence from investors in the company's innovative approach to addressing dry eye disease. This funding injection is expected to further propel Surface Pharmaceuticals' efforts in developing effective and timely recovery solutions for patients. As the company continues to pioneer advancements in ocular health, its recent investment underscores the potential for growth and impact within the pharmaceutical and biopharmaceutical sectors.

Taxonomy: Ocular health, Topical solutions, Dry eye disease, Pharmaceuticals, Ophthalmology solutions, Topical formulations, Medications, Klarity delivery system, Recovery, Ocular surface, Proprietary technology, Eye care, Medical technology, Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 10 Jun 2021
Series A •••••• 1
Investor
11 Jul 2018
Series A •••••• 1
Investor
15 May 2018

Surface Pharmaceuticals Alternatives & Competitors

Surface Pharmaceuticals vs
I-MED Pharma Inc.
I-MED Pharma Inc. Canada

SEE THE DIFFERENCE

51 employees
Medical Devices, Pharmaceutical
Surface Pharmaceuticals vs
BostonSight
BostonSight United States

A nonprofit healthcare organization that advances the treatment of diseased or damaged corneas and d...

46 employees
Surface Pharmaceuticals vs
OCCYO
OCCYO Austria

Intelligent Ocular Imaging

13 employees
Health Care, Manufacturing

FAQ About Surface Pharmaceuticals

Enhancing ocular health with advanced topical solutions for timely and effective dry eye disease recovery.
Surface Pharmaceuticals was founded in 2017.
Surface Pharmaceuticals operates in the following industries: Biopharma, Health Care, Pharmaceutical.
Surface Pharmaceuticals has completed 3 funding rounds, raising a total of $46.76M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Surface Pharmaceuticals include I-MED Pharma Inc., BostonSight, OCCYO, TearClear, iScience Interventional. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Surface Pharmaceuticals and I-MED Pharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Surface Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy